These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1632581)

  • 21. Pemoline abuse.
    Polchert SE; Morse RM
    JAMA; 1985 Aug; 254(7):946-7. PubMed ID: 4021028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
    Wang LJ; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Chen CK
    Psychopathology; 2016; 49(2):108-15. PubMed ID: 27071042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the development of spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Acta Psychiatr Scand; 1998 Mar; 97(3):220-7. PubMed ID: 9543311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Ann N Y Acad Sci; 2000 Sep; 914():292-302. PubMed ID: 11085329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Ann N Y Acad Sci; 1996 Oct; 801():415-29. PubMed ID: 8959056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
    Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
    Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Psychopharmacology (Berl); 1997 Dec; 134(3):303-8. PubMed ID: 9438680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced psychosis associated with crystalline methamphetamine.
    Dore G; Sweeting M
    Australas Psychiatry; 2006 Mar; 14(1):86-9. PubMed ID: 16630206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ishiguro T; Ikemoto S
    Drug Alcohol Depend; 1997 Mar; 44(2-3):183-7. PubMed ID: 9088791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic and clinical studies on methampetamine-related psychosis].
    Sato M
    Seishin Shinkeigaku Zasshi; 2002; 104(3):179-90. PubMed ID: 11985113
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P300 component of event-related potentials in methamphetamine psychosis and schizophrenia.
    Iwanami A; Suga I; Kaneko T; Sugiyama A; Nakatani Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):465-75. PubMed ID: 8078982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features of recent methamphetamine abusers: comparison between smoking abusers and injection abusers].
    Matsumoto T
    Seishin Shinkeigaku Zasshi; 2000; 102(5):498-513. PubMed ID: 10897680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine psychosis in Japan: a survey.
    Nakatani Y; Yoshizawa F; Yamada H; Iwanami A; Sakaguchi M; Katoh N
    Br J Addict; 1989 Dec; 84(12):1548-9. PubMed ID: 2611442
    [No Abstract]   [Full Text] [Related]  

  • 39. Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Nishijima K; Yoshino T; Ishiguro T
    Drug Alcohol Depend; 2001 Oct; 64(2):133-42. PubMed ID: 11543983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes of the dopamine uptake sites in the rat striatum induced by repeated methamphetamine administration: a neurochemical approach to a mechanism of relapse in amphetamine psychosis].
    Nakayama M
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):507-19. PubMed ID: 8340048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.